Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xiyue Yang
Anlotinib Combined With S-1 in the Third-Line Treatment of Stage IV Non-Small Cell Lung Cancer: Study Protocol for Phase II Clinical Trial
Asian Pacific Journal of Cancer Prevention
Related publications
Durvalumab in Frail and Elderly Patients With Stage Four Non-Small Cell Lung Cancer: Study Protocol of the Randomized Phase II DURATION Trial
Trials
Medicine
Pharmacology
Tasisulam Sodium (LY573636 Sodium) as Third-Line Treatment in Patients With Unresectable, Metastatic Non–Small-Cell Lung Cancer: A Phase-Ii Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
Oncologist
Cancer Research
Medicine
Oncology
Erlotinib Treatment in Pretreated Patients With Non-Small Cell Lung Cancer: A Phase II Study
Oncology Letters
Cancer Research
Oncology
Treatment Paradigms for Patients With Metastatic Non-Small-Cell Lung Cancer: First-, Second-, and Third-Line
Current Oncology
Oncology
Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients With Extensive-Stage Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Safety and Effectiveness of Localized Lung Resection Combined With Neoadjuvant Chemotherapy in the Treatment of Stage I-Ii Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Image Features for the Future in Stage IV Non-Small Cell Lung Cancer
Phase II Trial of Gefitinib in Combination With Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer With Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
